Synthesis and antimycobacterial activity of [5-(pyridin-2-yl)-1,3,4-thiadiazol-2-ylthio]acetic acid arylidene-hydrazide derivatives. 2001

M G Mamolo, and V Falagiani, and D Zampieri, and L Vio, and E Banfi
Dipartimento di Scienze Farmaceutiche, Università, di Trieste, Italy. mamolo@univ.trieste.it

[5-(Pyridin-2-yl)-1,3,4-thiadiazol-2-ylthio]acetic acid arylidene-hydrazide derivatives were synthesized and tested for their in vitro antimycobacterial activity. Some compounds showed a feable activity against a strain of Mycobacterium tuberculosis and a strain of Mycobacterium avium.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009161 Mycobacterium A genus of gram-positive, aerobic bacteria. Most species are free-living in soil and water, but the major habitat for some is the diseased tissue of warm-blooded hosts. Mycobacteria
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013830 Thiadiazoles Heterocyclic compounds composed of a five-membered heterocyclic ring which contains one sulfur and two nitrogen atoms. Thiadiazole

Related Publications

M G Mamolo, and V Falagiani, and D Zampieri, and L Vio, and E Banfi
March 2006, Bioorganic & medicinal chemistry letters,
M G Mamolo, and V Falagiani, and D Zampieri, and L Vio, and E Banfi
October 2005, Bioorganic & medicinal chemistry letters,
M G Mamolo, and V Falagiani, and D Zampieri, and L Vio, and E Banfi
January 2017, Iranian journal of pharmaceutical research : IJPR,
M G Mamolo, and V Falagiani, and D Zampieri, and L Vio, and E Banfi
January 2015, Acta chimica Slovenica,
M G Mamolo, and V Falagiani, and D Zampieri, and L Vio, and E Banfi
February 2007, Archives of pharmacal research,
M G Mamolo, and V Falagiani, and D Zampieri, and L Vio, and E Banfi
October 2013, Bioorganic & medicinal chemistry letters,
M G Mamolo, and V Falagiani, and D Zampieri, and L Vio, and E Banfi
August 2007, Bioorganic & medicinal chemistry,
M G Mamolo, and V Falagiani, and D Zampieri, and L Vio, and E Banfi
July 2019, Bioorganic & medicinal chemistry letters,
M G Mamolo, and V Falagiani, and D Zampieri, and L Vio, and E Banfi
March 1984, Journal of pharmaceutical sciences,
Copied contents to your clipboard!